Europe is administering four vaccines to prevent severe forms of Covid-19. Pfizer-BioNTech, Moderna, AstraZeneca (Vaxzevria) and Johnson&Johnson (Janssen). Therefore, we have compared them.
To clarify, the European Medicines Agency has authorized four vaccines for people in European countries. These are Pfizer-BioNTech, Moderna, AstraZeneca (Vaxzevria) and Johnson&Johnson (Janssen). Nevertheless, evaluation on others is going on: Sputnik V vaccine (Russia), CureVac vaccine (Germany), Sanofi-GSK vaccine, Novavax vaccine and CoronaVac (by Sinovac).
Europe has authorized four vaccines :
To sum up, the vaccines use different modalities of action. But all target the Spike protein of the Sars-CoV-2 virus, which allows the cellular penetration of the virus. Of course, vaccination enables the activation of the immune system. The germ that enters a vaccinated person’s body will come up against his immune system prepared to receive it.
Vaccines developed against COVID-19 use different technologies:
Covid-19 Vaccine from attenuated or inactivated viruses: vaccine containing infectious agents killed but capable of responding to the immune system. But, this type of vaccine requires large amounts of viruses.
Covid-19 Vaccine from viral proteins: The coronavirus has on its surface spikes “spicules”. “Spicules” allow it to come into contact with the cells it will infect. But, These spikes are viral proteins that have been isolated in the laboratory. Thus, they can be manufactured and injected to make the immune system react to these foreign molecules.
Covid-19 Vaccine from DNA or Viral mRNA (Pfizer / Moderna): A genetic sequence of the virus (DNA or mRNA) is injected and enters inside the human cell. Consequently, this will use it to produce the associated viral protein that will react the immune system.
Covid-19 Vaccine from viral vectors (AstraZeneca / Johnson & Johnson): a specialized attenuated virus (= vector) is used to convey the elements necessary for the future protection (the protein (s) of interest and/or its sequence ( s) Genetic (s)) to our cells and thus expose them to our immune system.
Still, only the long term can demonstrate the effectiveness of a Covid-19 Vaccine. It is necessary to expose both vaccinated and unvaccinated individuals to the virus in a risk area. So, this to demonstrate that the virus affects vaccinated population less than the unvaccinated population. However, this necessarily requires a long time. Today, specialists agree that it takes at least six months to analyze the antibody level of vaccinated people. Of course, this analyze is a guarantee of their protection.
Vaccine Corminaty® (Pfzer-BioNTech) | Vaccin e mRNA Moderna | Vaccine AZD1222 AstraZeneca | Vaccine Janssen (Johnson&Johnson) | |
---|---|---|---|---|
Overall efficacy rate revealed in Phase 3 clinical trials | 95% | 90% | 60-70% | 67% |
The results of clinical studies of Covid-19 Vaccine candidates seem to converge to demonstrate the main fact. vaccination massively reduces mortality from the virus and its severe forms. Therefore, the effectiveness of the vaccine sought today is the protection of the risk of severe forms. However, we do not know whether it can protect against the transmission of the virus.
Specifically, One dose of Covid-19 Vaccine for those who got the Covid:
This is for people who the Covid-19 has already contaminated of course. The specialists recommend waiting a minimum of 3 months before being vaccinated. Or even “getting closer to 6 months and using only one dose of vaccine in this case.
Severely immunocompromised individuals may require the third dose of mRNA vaccine. Indeed, this third injection should be given at least four weeks after the second dose or as soon as possible for people who have already exceeded this time.
Finally, like any medication, a vaccine can have side effects.
If you want to buy from Turkey products to prevent Covid-19 , please visit our Turkish Health&Medical Industry category.